CIK 0001588978 · Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260199180
- Phone
- 6502329832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-12 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −22,349 | 51,927 | ||
| 2024-02-09 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +28,677 | $4.52 | $130K | 62,200 |
| 2024-02-09 | Waters Kevin EVP, CFO | Sale 10b5-1 | −28,677 | $50.09 | $1.4M | 33,523 |
| 2024-02-09 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −28,677 | 74,276 | ||
| 2024-02-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +14,694 | $5.18 | $76K | 62,045 |
| 2024-02-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −14,694 | $49.97 | $734K | 47,351 |
| 2024-02-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −14,694 | 20,125 | ||
| 2024-02-07 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +904 | $4.52 | $4K | 34,427 |
| 2024-02-07 | Waters Kevin EVP, CFO | Sale 10b5-1 | −904 | $50.00 | $45K | 33,523 |
| 2024-02-07 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −904 | 102,953 | ||
| 2024-02-07 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +5,306 | $5.18 | $27K | 52,657 |
| 2024-02-07 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −5,306 | $49.95 | $265K | 47,351 |
| 2024-02-07 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,306 | 34,819 | ||
| 2024-01-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +16,000 | $4.56 | $73K | 63,351 |
| 2024-01-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Sale 10b5-1 | −16,000 | $44.97 | $719K | 47,351 |
| 2024-01-09 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,000 | 13,697 | ||
| 2024-01-09 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +17,310 | $4.52 | $78K | 50,833 |
| 2024-01-09 | Waters Kevin EVP, CFO | Sale 10b5-1 | −17,310 | $45.07 | $780K | 33,523 |
| 2024-01-09 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,310 | 103,857 | ||
| 2023-12-15 | Nouri Alaleh EVP, CLO, CORP. SEC. | Option exercise 10b5-1 | +11,796 | $4.56 | $54K | 58,729 |
Page 15 of 25 · 483 trades